 |
Offer your patients a positive experience.
Patients undergoing breast procedures have enough worries. Help put their minds at ease by using trusted LigaSure™ technology which has been used in over 35 million procedures with more than 25 years of proven performance in many types of surgical procedures/specialties.1,2,†
Contact your local rep to demo the LigaSure™ Exact dissector
Using the LigaSure™ Exact dissector in breast procedures can give your patients:
Over 50% reduction in
drainage volume3,‡
Over 50% seroma reduction3,‡
Nearly 90% lymphedema reduction,4,‡
Nearly 4 fewer days of
hospital stay3,ΩΩ
Deliver confidence.
With LigaSure™ technology, you get:
- Precise blunt dissection5,§
- Cool jaw temperature profile6,Ω
- Just 1 mm thermal spread protecting nearby structures like nerves and the axillary vein7
The LigaSure™ Exact dissector helps to decrease lymphatic leakage, seroma and lymphedema after total mastectomy with axillary lymph node dissection.3,4,‡
Deliver healing.
With V-Loc™ wound closure device, you get:
- Reduced wound inflammation12,††,‡‡
- Potential exhibit lower adverse tissue reactivity12,††,‡‡
- Potential reduction in wound ischemia and improved wound healing12,††,‡‡
Give the V-Loc™ device a try.
Your free experience kit gives you a hands-on opportunity to feel what it's like to suture with the V-Loc™ device.
The regulatory status of LigaSure™ Exact dissector is independent from that of V-Loc™ wound closure device.
The LigaSure™ Exact dissector is intended for use only with compatible Covidien generators. Use of this instrument with other generators may not result in the desired tissue effect, may result in injury to the patient or surgical team, or may cause damage to the instrument.
V-Loc™ 90 wound closure device. Do not tie knots. Tying knots may damage the barbs and potentially reduce their effectiveness. As with all surgical sutures, adverse effects include but are not limited to
wound dehiscence, and failure to provide adequate wound support in sites where expansion, stretching, or distention occur
The safe and effective use of RF energy depends on many factors solely under the control of the operator. There is no substitute for properly trained and vigilant personnel. It is important that the operating instructions supplied with this or any other medical equipment be read, understood, and followed.
† Based on internal sales data from FY01-FY23. November 2023.
‡ Compared to conventional methods/electrosurgery
§ 22 out of 23 surgeons surveyed agreed
Ω after 5 activations
†† As compared to conventional sutures.
‡‡ Animal data may not correlate with human clinical outcomes.
ΩΩ Compared to conventional electrocautery technique (5.9 vs 9.6 days, p<0.001).
1. Advanced Energy Procedures Claim_US161132(4) vCertification 1.1_10.24.19
2. Advanced Energy Historical Sales Data_FY20 Sept.
3. Ikeda N, Akahori T, Yokotani T, Fujii T, Sho M. Total Sealing Technique (TST) with a bipolar vessel sealing system reduces lymphorrhea and seroma formation for axillary lymph node dissection in primary breast cancer. Surg Open Sci. 2024; 19:1-7.
4. Ikeda, N.; Nagata, T.; Umemura, T.; Watanabe, M. Total Sealing Technique: A Preliminary Study on a Novel Surgical Approach That Significantly Reduces the Incidence of Upper Extremity Lymphedema Following Axillary Dissection in Patients with Breast Cancer. Cancers 2025, 17, 1285.
5. RE00114823_A RPT Surgeon Validation of LigaSure™ Exact LF2019
6. RE00107711_Harmonic Focus vs LigaSure Exact LF2019
7. R000153866_A RPT_Exact_Comp_Acute
8. Lee JS, Kim DG, Lee JW, et al. Usefulness of the LigaSure small jaw sealing device for breast reconstruction with a latissimus dorsi flap. J Plast Surg Hand Surg. May 2019:1–6.
9. Chang YW, Kim HS, Jung SP, et al. Comparison of skinsparing mastectomy using LigaSure Small Jaw andelectrocautery. World J Surg Oncol. 2017;15(1):129.
10. Seki T, Hayashida T, Takahashi M, Jinno H, Kitagawa Y. A randomized controlled study comparing a vesselsealing system with the conventional technique in axillary lymph node dissection for primary breast cancer.
Springerplus. 2016;5(1):1004.
11. Inoue Y, Yamashita N, Ueo H, et al. The Clinical Usefulness of the LigaSure Small Jaw in Axillary LymphNode Dissection in Patients with Breast Cancer. Anticancer Res. 2018;38(4):2359–2362.
12. Zaruby J, Gingras K, Taylor J, Maul D. An in vivo comparison of barbed suture devices and conventional monofilament sutures for cosmetic skin closure: biomechanical wound strength and histology. Aesthet Surg J. 2011;31(2):232-40.
©2025 Medtronic. All rights reserved, Medtronic. Medtronic logo and Engineering the extraordinary are trademarks of Medtronic. All other brands are trademarks of a Medtronic company. 09/2025 - US-SE-2200214
Operational Headquarters 710 Medtronic Parkway, Minneapolis, MN 55432-5640 USA
©2025 Medtronic
